President Trump announced all 50 states will join a Medicaid drug pricing model using Most Favored Nation principles to lower costs. While the administration claims billions in savings, experts questi
President Trump's drug pricing initiative faces resistance from mid-sized pharmaceutical firms during a Medicaid pilot, despite major players signing deals covering 86% of the market. Smaller innovato
U.S. President Trump issued an executive order to accelerate psychedelic drug development, aiming to shorten FDA review timelines and improve DEA coordination. Investors anticipate reduced regulatory
ChemBrief